463,396 kids.
That’s the size of the dataset. Not a survey. Not an estimate. Actual electronic health records from Kaiser Permanente. They tracked these adolescents from ages 13 through 26.
The results landed in JAMA Health Forum on Feb 20 2026. The message is blunt. Using cannabis as a teen links to serious mental illness later. Not mild sadness. We are talking psychotic disorders. Bipolar disorder. Anxiety.
The risk doubles for psychotic and bipolar diagnoses.
Depression and anxiety went up too. Just not as sharply.
“Cannabis exposure during the teen years may be…” a risk factor.
Researchers call it a risk. I call it a warning shot.
The study didn’t look at only the heaviest users. It looked at any reported use in the past year. Routine screening at pediatric visits caught this. It makes the data messy, sure, but real. Kids are using weed. Then they get sick.
Usually the weed use started 1.7 to two years before the diagnosis hit. That gap matters. It suggests causality. Or at least a very strong timeline.
Lynn Silver from the Public Health Institute puts it plainly. Products are getting stronger. Marketing is getting aggressive. Teens are drinking poison and calling it relaxation.
Think about the numbers.
Average THC in California flower exceeds 20%. Concentrates? Over 95%. That’s not what the counterculture smoked in 1970. It’s chemically distinct.
Usage climbs as kids age. 8th graders hit about 8%. By 12th grade, it’s 26%. The National Survey on Drug Use confirms it. Over 10% of all U.S. teens aged 12-17 used it last year.
Kelly Young-Wolff led the analysis. She notes the risks remain even after controlling for prior issues. This isn’t just correlation hiding cause.
It gets worse.
The data shows higher use among Medicaid patients and kids in poorer neighborhoods. Commercial cannabis could worsen existing gaps in mental health. Rich kids get protected. Poor kids get hit harder.
Is it just the plant?
Probably not entirely. But it’s the vector. The gateway isn’t metaphorical anymore. It’s biological.
We need honest conversations. Not moralizing lectures. Facts. The facts are bad right now.
Preventive measures? Lower potency limits. Stop marketing to minors. Treat teen usage as a health crisis, not a rite of passage.
The evidence piles up.
Parents want trusted info. They don’t get it from school counselors or internet forums. They get anxiety.
The study leaves one question hanging.
How many diagnoses will we chalk up to “development” before we admit it’s the drug?
We’re finding out. Slowly.
